Fidelity Investments
NMRD

Fidelity Investments’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Fidelity Investments’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-44
Closed – – 4664
2020
Q4 		$0 Buy
+44
New +$170 ﹤0.01% 4374

Other funds holding NMRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments's NMRD Position: Q1 2021 in Review

Fidelity Investments sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2021, closing a stake of 44 shares.

Fidelity Investments first reported a position in NMRD in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 30 funds tracked by Wall St. Rank hold NMRD as of Q1 2021.

  • Fidelity Investments reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Fidelity Investments sold 44 Nemaura Medical, Inc. Common Stock shares in Q1 2021.
  • Fidelity Investments first reported a position in Nemaura Medical, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Fidelity Investments's Nemaura Medical, Inc. Common Stock position peaked at $0 in Q4 2020.
  • 30 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2021.

Based on Fidelity Investments's 13F filing for Q1 2021, filed 14 May 2021.